We had recommended MCX in Volume No 34 Issue No 1 (dated Oct. 23, 2017) when the scrip was trading at Rs 1110. Our recommendation was based on fundamental and technical factors. The Q3FY18 numbers are out and the company's revenue de-grew by 11.2 per cent YoY while operating profit and net profit declined by 29.8 per cent and 44.7 per cent, respectively. The ADT in commodity futures decreased by 3.7 per cent YoY,
We had recommended MCX in Volume No 34 Issue No 1 (dated Oct. 23, 2017) when the scrip was trading at Rs 1110. Our recommendation was based on fundamental and technical factors. The Q3FY18 numbers are out and the company's revenue de-grew by 11.2 per cent YoY while operating profit and net profit declined by 29.8 per cent and 44.7 per cent, respectively. The ADT in commodity futures decreased by 3.7 per cent YoY,
The year 2017 gave handsome returns to the invesÂtors, who flooded the markets with funds through MFs/SIPs. Relentless movement in the mid-cap and small-cap stocks led to the rise in the markets. However, the recent reduction in the exposure of mutual funds to these segments amid overvaluation started off cyclical correction, with SEBI disallowing swapping of stocks within the categories
After reacting positively to the robust macroeconomic numbers, Indian stock markets witnessed consolidation at record high levels. This was in the wake of investors’ provisional transition to major commodities from equities. Crude oil prices surged ahead of their three-year high levels amid flat production at 32.41mbpd by OPEC in December, apart from protests in Iran. Gold hit new highs with demand pick-up from domestic jewellers, supported by overall strong global trend, amid weak US dollar. Further, the markets remained cautious ahead of the Q3 corporate earnings season kicking-off. In the near-term, corporate earnings, inflation numbers are estimated to hit 5 per cent plus which would drive the markets.
The company is engaged in manufacturing of paints, varÂnishes, enamels or lacquers, organic and inorganic comÂpounds. The company commands 11.1 per cent market share in terms of revenue and is the fourth largest player in the paints industry in India. Its PAT has grown at a CAGR of 31.5 per cent over FY15-17. It has delivered ROE of 20.9 per cent on a TTM basis. The
Of late, the Indian stock markets are seen hovering around their peak levels while both bulls and bears appeared to have spent their forces. The January effect was visible in the markets with a bounce back driven by robust auto sales numbers for the month of December. The auto sector witnessed pick-up in car sales, especially with luxury car sales growing at fastÂest pace in the last half decade. Further, the positive momentum in the manufacturing and services PMI carried forward the optimism in the markets. Nikkei India manufacturing PMI surged at its fastest pace in the last five years at 54.7 as against 52.6 in the previÂous month. The surge was led by rise in merchandise exports at 30.5%, plus 6.8% growth in
Indraprastha Medical Corporation
The year 2017 has been a cheerful year for the Indian stock markets, despite major upstream events trying to restrain investors. Considering the long-term benefits of the tax reform (GST), realty regulatory framework (RERA), regulatory framework for NPAs of banks, digitisation and 'Smart City' initiatives, the smart investors kept pouring in throughout the year. Rather, the Indian markets outpaced all the emerging markets and also the developed peers like the US and Japan, where the benchmark indices soared as much as 28% during the year.